mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.32 |
6e-07 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.29 |
4e-06 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.0006 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.002 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.18 |
0.002 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.003 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.004 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.007 |